PMV Pharmaceuticals Statistics

Total Valuation

PMVP has a market cap or net worth of $82.82 million. The enterprise value is -$106.48 million.

Market Cap	82.82M
Enterprise Value	-106.48M

Important Dates

The next estimated earnings date is Wednesday, May 8, 2024, before market open.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

PMVP has 51.44 million shares outstanding. The number of shares has increased by 5.31% in one year.

Shares Outstanding	51.44M
Shares Change (YoY)	+5.31%
Shares Change (QoQ)	+4.77%
Owned by Insiders (%)	2.95%
Owned by Institutions (%)	99.55%
Float	41.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.78, with a Debt / Equity ratio of 0.06.

Current Ratio	14.78
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.30% and return on invested capital (ROIC) is -33.53%.

Return on Equity (ROE)	-30.30%
Return on Assets (ROA)	-27.30%
Return on Capital (ROIC)	-33.53%
Revenue Per Employee	n/a
Profits Per Employee	-$1.09M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, PMVP has paid $2,000 in taxes.

Income Tax	2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.22% in the last 52 weeks. The beta is 1.64, so PMVP's price volatility has been higher than the market average.

Beta (1Y)	1.64
52-Week Price Change	-64.22%
50-Day Moving Average	1.70
200-Day Moving Average	3.72
Relative Strength Index (RSI)	47.52
Average Volume (30 Days)	589,359

Short Selling Information

The latest short interest is 2.60 million, so 5.06% of the outstanding shares have been sold short.

Short Interest	2.60M
Short Previous Month	2.26M
Short % of Shares Out	5.06%
Short % of Float	6.34%
Short Ratio (days to cover)	3.73

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-80.13M
Pretax Income	-68.96M
Net Income	-68.96M
EBITDA	-68.07M
EBIT	-68.96M
Earnings Per Share (EPS)	-$1.44

Full Income Statement

Balance Sheet

The company has $203.88 million in cash and $13.29 million in debt, giving a net cash position of $190.59 million or $3.70 per share.

Cash & Cash Equivalents	203.88M
Total Debt	13.29M
Net Cash	190.59M
Net Cash Per Share	$3.70
Equity / Book Value	225.69M
Book Value Per Share	4.39
Working Capital	193.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.66 million and capital expenditures -$962,000, giving a free cash flow of -$56.62 million.

Operating Cash Flow	-55.66M
Capital Expenditures	-962,000
Free Cash Flow	-56.62M
FCF Per Share	-$1.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.31%
Shareholder Yield	-5.31%
Earnings Yield	-81.99%
FCF Yield	-67.32%

Analyst Forecast

The average price target for PMVP is $8.00, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	400.00%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2